During the past decade, Massachusetts General Hospital- Center for Anxiety and Traumatic Stress Disorders conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Massachusetts General Hospital- Center for Anxiety and Traumatic Stress Disorders" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cerebral Sciences LLC" with 1 trials as a collaborator, "NYU Langone Health" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Massachusetts General Hospital- Center for Anxiety and Traumatic Stress Disorders" are "Generalized Anxiety Disorder" (3 trials), "Bipolar Disorder" (1 trials), "Cognitive Change" (1 trials), "Major Depressive Disorder" (1 trials) and "Major Depressive Disorder With Mixed Features" (1 trials). Many other conditions were trialed in "Massachusetts General Hospital- Center for Anxiety and Traumatic Stress Disorders" in a lesser frequency.

Most popular intervention types in "Massachusetts General Hospital- Center for Anxiety and Traumatic Stress Disorders" are "Drug" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Lurasidone" (2 trials), "Placebo" (2 trials), "Transcranial Light Therapy" (2 trials), "Aripiprazole" (1 trials) and "Ziprasidone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Massachusetts General Hospital- Center for Anxiety and Traumatic Stress Disorders" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Massachusetts General Hospital- Center for Anxiety and Traumatic Stress Disorders". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Massachusetts General Hospital- Center for Anxiety and Traumatic Stress Disorders, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Massachusetts General Hospital- Center for Anxiety and Traumatic Stress Disorders, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".